Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Eli Lilly and Company
Pfizer
Pfizer
AstraZeneca
Genentech, Inc.
Eli Lilly and Company
University of Southern California
Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc.
Hummingbird Bioscience
Eli Lilly and Company
Taiho Pharmaceutical Co., Ltd.
Coherus Oncology, Inc.
Shanghai Jiao Tong University School of Medicine
Syros Pharmaceuticals
Canadian Cancer Trials Group
Seagen Inc.
Roswell Park Cancer Institute
Eli Lilly and Company
Gossamer Bio Inc.
Novartis
Bayer
Bristol-Myers Squibb
Eli Lilly and Company
AstraZeneca
Gilead Sciences
Incyte Corporation
Celgene
AstraZeneca
Merck Sharp & Dohme LLC
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
GlaxoSmithKline
GlaxoSmithKline
Northwestern University
Dana-Farber Cancer Institute
Hoffmann-La Roche
EMD Serono
Sanofi
Altor BioScience
NewVac LLC
Washington University School of Medicine
Merck Sharp & Dohme LLC
Radiation Therapy Oncology Group
Debiopharm International SA
Amgen
National Cancer Institute (NCI)